BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 1, 2008
View Archived Issues
Ascorbate demonstrates anticancer activity in vitro and in vivo
Read More
IL-21 immunologically active in patients with metastatic melanoma, renal cell carcinoma
Read More
Johnson & Johnson research into tryptase inhibitors continues with new compounds
Read More
PEG coating allows nanoparticles to penetrate the mucus barrier
Read More
Immunoglobulin intravenous appears safe over 48 weeks in CIDP patients
Read More
S-Methylisothiourea reduces cerebral ischemia damage in vivo
Read More
QseC signaling inhibition with LED-209 blocks bacterial vigilance
Read More
Novel p38 MAP kinase inhibitors synthesized at Palau Pharma
Read More
Growth hormone secretagogue BMS-606056 displays promising preclinical characteristics
Read More
Transgene and Roche modify clinical development program for TG-4001/R-3484
Read More
Eisai offers Q1 overview
Read More
Recent sanofi-aventis patent discloses new analgesic agents
Read More
Novel therapeutic agents for glaucoma reported in recent Allergan patents
Read More
Arpida submits NDS for intravenous iclaprim in Canada
Read More
Recent patents disclose novel antiinfective agents
Read More
Overall survival results reported in Erbitux phase III lung cancer study
Read More
Shionogi acquires U.S.-based Sciele Pharma
Read More
sanofi-aventis acquires Symbion
Read More
EMEA approves Intelence for the treatment of HIV
Read More
Taxotere Injection approved in Japan for prostate cancer
Read More